REQUEST A DEMO
Total
USD $0.00
Search more companies

Korea Arlico Pharm Co.,Ltd. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing | Medicinal and Botanical Manufacturing
Full name: Korea Arlico Pharm Co.,Ltd. Profile Updated: July 04, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English Download a sample report

Korea Arlico Pharm Co.,Ltd. is engaged in the researching and development of medicines. The company also provides ETC, OTC, health functional, and other products; and active ingredients. Korea Arlico Pharm Co.,Ltd. offers products in the areas of circulatory system, anti-platelet, dementia, muscle relaxants, diabetes, nsaids and analgesics, antibiotic and chemotherapy, allergy and respiratory disease, ointment/cream, health functional food, vitamin and health supplements, anti-inflammatory analgesic, digestive system, and metabolic disease. The company was founded in 1992 and is based in Seoul, South Korea.

Headquarters
7-21, Baumoe-ro 27-gil Seocho-gu Seoul
Seoul; Seoul;

Contact Details: Purchase the Korea Arlico Pharm Co.,Ltd. report to view the information.

Basic Information
Total Employees:
Purchase the Korea Arlico Pharm Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Korea Arlico Pharm Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Korea Arlico Pharm Co.,Ltd. report to view the information.
Incorporation Date:
October 01, 1992
Key Executives
Purchase this report to view the information.
CEO
Purchase this report to view the information.
Non-Executive Independent Director
Purchase this report to view the information.
Non-Executive Independent Director
Purchase this report to view the information.
Non-Executive Independent Director
Purchase this report to view the information.
Executive Director
Ownership Details
Purchase this report to view the information.
41%
Purchase this report to view the information.
6.3%
Purchase this report to view the information.
2.6%
Company Performance
Financial values in the chart are available after Korea Arlico Pharm Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
19.68%
Total operating revenue
19.68%
Operating profit (EBIT)
105.75%
EBITDA
75.35%
Net Profit (Loss) for the Period
62.98%
Total assets
26.82%
Total equity
9.14%
Operating Profit Margin (ROS)
2.46%
Net Profit Margin
1.27%
Return on Equity (ROE)
2.99%
Debt to Equity Ratio
9.76%
Quick Ratio
-0.5%
Cash Ratio
0.13%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?